Beam Therapeutics (BEAM) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

BEAM Beam Therapeutics

Watchlist

24.910
+0.450+1.84%

Close Aug 8 16:00 ET

24.380
-0.530-2.13%

Post 17:41 ET

2.05BMarket Cap-15376P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Beam Therapeutics Price Target Cut to $31.00/Share From $33.00 by Barclays
Dow JonesAug 7 12:48 ET · Ratings
Beam Therapeutics Is Maintained at Equal-Weight by Barclays
Dow JonesAug 7 12:48 ET
Express News | RBC Capital Reiterates Sector Perform on Beam Therapeutics, Maintains $27 Price Target
BenzingaAug 7 11:36 ET
Beam Therapeutics Analyst Ratings
BenzingaAug 7 11:35 ET · Ratings
Beam Therapeutics (BEAM) Q2 Earnings Beat, Revenues Miss
Zacks Aug 7 09:55 ET
Analysts Conflicted on These Healthcare Names: Nyxoah (NYXH), MultiPlan (MPLN) and Beam Therapeutics (BEAM)
TipRanksAug 7 07:01 ET · Ratings

Comments

ClydePeternuts

Jul 17 03:06

Cathie Wood and Ark Invest's trade activity from 2024/07/16

Buys🟢\\ $Beam Therapeutics (BEAM.US)$ $Oklo Inc (OKLO.US)$
Sells🔴\\ $Zoom Video Communications (ZM.US)$ $Trimble (TRMB.US)$ $Twist Bioscience (TWST.US)$ $UiPath (PATH.US)$

frankinglily

May 14 03:38

How does the biotech ecosystem support advancements in personalized medicine & genomics?
• Editing Genes | $CRISPR Therapeutics (CRSP.US)$ , $Intellia Therapeutics (NTLA.US)$ , $Beam Therapeutics (BEAM.US)$ , $Verve Therapeutics (VERV.US)$ , $Editas Medicine (EDIT.US)$
• Creating Therapies | $Prime Medicine (PRME.US)$ , $Sana Biotechnology (SANA.US)$
• Building DNA | $Twist Bioscience (TWST.US)$ , $Ginkgo Bioworks (DNA.US)$ , $Pacific Biosciences of California (PACB.US)$ , $Illumina (ILMN.US)$
• Dis...

PaulG

Feb 27 14:10

$Beam Therapeutics (BEAM.US)$ Will double to 90 dollars 💸 💵 💲

Kevin Travers

Feb 27 10:02

Columns Biotechnology Stocks Climbing on Earnings and Test Results: What to Watch

$Viking Therapeutics (VKTX.US)$skyrocketed 77% after positive drug trial news Tuesday, leading to what proved to be a strong morning for pharmaceutical stocks.
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...

Moomoo AI

Dec 14, 2023 05:35

Beam Therapeutics' CEO, John Evans showed confidence in Ms. Shaw's ability to turn scientific innovations into commercial treatments. Shaw recognizes Beam's groundbreaking work in genetic medicine and gene editing, predicting major clinical milestones ahead thanks to the company's comprehensive platform and capabilities.